Iovance Biotherapeutics (NASDAQ:IOVA) Trading Down 5.8% Following Analyst Downgrade
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report)’s share price dropped 5.8% on Tuesday after Truist Financial lowered their price target on the stock from $25.00 to $15.00. Truist ...
Iovance Biotherapeutics (NasdaqGM:IOVA) Stock Dips 27% Despite Reaffirmed 2025 Earnings Guidance
Iovance Biotherapeutics (NasdaqGM:IOVA) recently reaffirmed its earnings guidance for 2025 and projected significant revenue growth for 2026, alongside announcing a notable revenue increase in its ...
Iovance Biotherapeutics price target lowered to $30 from $34 at Chardan
Chardan lowered the firm’s price target on Iovance Biotherapeutics (IOVA) to $30 from $34 and keeps a Buy rating on the ...
Iovance Biotherapeutics (IOVA) Gets a Buy from Truist Financial
In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Iovance Biotherapeutics (IOVA – Research ...
Barclays Sticks to Its Buy Rating for Iovance Biotherapeutics (IOVA)
In a report released today, Peter Lawson from Barclays maintained a Buy rating on Iovance Biotherapeutics (IOVA – Research Report), with a ...
What is HC Wainwright’s Estimate for IOVA Q1 Earnings?
Stock analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of Iovance Biotherapeutics in a report issued ...